Published Date: 08 Mar 2023
Interventions to improve clinical practice increased the odds that people with type 2 diabetes and heart disease were prescribed the drugs recommended in our study by more than 100%.
Read Full NewsThe thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.
Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.
1.
Study suggests exercise could reduce breast cancer recurrence
2.
Dense breasts: What it means and what women can do about screening
3.
Exercise may help breast cancer survivors manage weight
4.
For patients with prostate cancer, long-term follow-up helps identify treatment side effects.
5.
New CAR T-Cell Therapy Approved for Leukemia
1.
Evolutionary Bottlenecks in Tumor Progression
2.
PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision
3.
Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies
4.
Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored
5.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
2.
Navigating the Complexities of Ph Negative ALL - Part III
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation